Sierra Oncology to licence myelofibrosis candidate from AstraZeneca
August 6, 2021Medical Communications, Research and Development, Sales and Marketing
Under a new agreement announced on Friday, AstraZeneca will licence AZD5153, a potent and selective BRD4 BET inhibitor with a …
Gilead warns of counterfeit HIV medication being distributed in US
August 6, 2021Medical Communications
Gilead have released a statement warning of tampered and counterfeit versions of its once-daily single tablet HIV treatment regimen Biktarvy …
Libtayo Phase III Trial stopped early due to significant improvement in overall survival
August 6, 2021Medical Communications
The Phase III trial of Sanofi and Regeneron’s PD-1 inhibitor Libtayo in combination with platinum-doublet chemotherapy was stopped early due …
FDA grants Orphan Drug Designation to sotigalimab for soft tissue sarcoma
August 6, 2021Medical Communications
The FDA has granted Apexigen’s sotigalimab (APX005M) Orphan Drug Designation for the treatment of soft tissue sarcoma.Sotigalimab, Apexigen’s lead therapeutic …
Cholesterol pill could cut COVID infections by up to 70%, study finds
August 6, 2021Medical Communications, Research and Development
A licensed drug normally used to treat abnormal levels of fatty substances in the blood could reduce COVID infections by …
Fresenius launches VR training for home dialysis in Germany
August 5, 2021Fresenius has launched a virtual reality-based training programme, stay safe My Training VR, for people undergoing at home dialysis.The VR …
Study finds pressured oxygen reduces ventilator need in COVID patients
August 5, 2021Medical Communications
Treating COVID patients with acute respiratory failure with continuous positive airway pressure (CPAP) reduces the need for invasive mechanical ventilation, …
NICE and AHSN to collaborate on best evidence-based healthcare
August 5, 2021NICE and the Academic Health Science Network (AHSN) are to collaborate on best evidence-based healthcare to improve the lives of …
CMA accuses Pfizer and Flynn of overcharging the NHS
August 5, 2021Having gathered further evidence, the CMA has reached a provisional view that Pfizer and Flynn broke competition law by charging …
One in five of all UK COVID hospital admissions are aged 18-34
August 5, 2021One fifth of all UK COVID hospital admissions are now from people aged 18-34, which is four times higher than …
Tokyo COVID: Cases surge as Delta variant takes hold, hospital policy U-turn expected
August 4, 2021Medical Communications, Research and Development
Japan has warned that COVID-19 cases are surging at an ‘unprecedented pace’, hitting record highs in Tokyo amid the Olympic …
Delta surge: China reports highest rate of new COVID cases since Jan
August 4, 2021Medical Communications, Research and Development
On Wednesday China reported the highest number of new locally transmitted COVID-19 cases since January, with case numbers being driven …
Chilean study reveals success of various COVID-19 vaccines
August 4, 2021Research and Development
Chilean authorities have released real world data on the varied success of the Sinovac, Pfizer, and AstraZeneca COVID-19 vaccines.Among the …
Eli Lilly to seek approval for experimental Alzheimer’s drug by end of year
August 4, 2021Research and Development
Eli Lilly and Co plans to seek US approval for its experimental Alzheimer’s drug by the end of the year, …
Over 1 million 16 and 17-year-olds set to be offered vaccine in UK
August 4, 2021Research and Development
UK experts are near announcing that all 16 and 17-year-olds should be offered a COVID vaccine in the UK, as …
Novartis set to launch new Zolgensma trial to expand use
August 3, 2021Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Novartis has announced that it will launch a new Phase III study to expand the use of Zolgensma – the …
Cannabis-based oral spray could kill brain tumours, study to launch next year
August 3, 2021Manufacturing and Production, Medical Communications, Research and Development
The NHS alongside cancer charities are set to launch a clinical trial to investigate the effects of a cannabis-based oral …
Sanofi to buy Translate Bio for $3.2 billion
August 3, 2021Manufacturing and Production
Sanofi has agreed to buy U.S. biotech company Translate Bio in a $3.2 billion deal.This is part of Sanofi’s goal …
NICE approves UCB’s bimekizumab through expedited review process
August 3, 2021Manufacturing and Production
NICE has published draft guidance on the first treatment to use its new review process, recommending UCB’s bimekizumab for treating …
FDA approves AstraZeneca’s anifrolumab for treating lupus
August 3, 2021Manufacturing and Production
The FDA has approved Saphnelo (anifrolumab) for the treatment of moderate-to-severe systemic lupus erythematosus (SLE), the most common form of …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
